Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.05)
# 1,057
Out of 5,182 analysts
908
Total ratings
40.63%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio | Reiterates: Buy | $13 | $5.19 | +150.48% | 2 | May 5, 2026 | |
| TVTX Travere Therapeutics | Maintains: Buy | $47 → $57 | $43.82 | +30.08% | 8 | May 5, 2026 | |
| KRYS Krystal Biotech | Reiterates: Buy | $310 | $286.21 | +8.31% | 36 | May 4, 2026 | |
| CLNN Clene | Reiterates: Buy | $31 | $7.04 | +340.34% | 32 | May 4, 2026 | |
| ESPR Esperion Therapeutics | Downgrades: Neutral | $3.16 | $3.13 | +0.96% | 31 | May 1, 2026 | |
| XOMA XOMA Royalty | Downgrades: Neutral | $39 | $41.46 | -5.93% | 27 | Apr 30, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $243 → $289 | $231.68 | +24.74% | 25 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $24 | $1.85 | +1,197.30% | 19 | Apr 27, 2026 | |
| GUTS Fractyl Health | Reiterates: Buy | $8 | $0.70 | +1,039.60% | 4 | Apr 24, 2026 | |
| STTK Shattuck Labs | Maintains: Buy | $6 → $18 | $6.64 | +171.08% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $20 | $14.21 | +40.75% | 6 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.08 | +1,293.53% | 34 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $13 | $6.20 | +109.68% | 7 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $1.2 | $0.82 | +45.80% | 17 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $16.55 | +123.56% | 18 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.46 | +518.56% | 14 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.62 | +271.52% | 25 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $31.95 | +219.25% | 36 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $33.51 | +79.05% | 29 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.66 | - | 19 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.50 | +580.00% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $15 | $9.41 | +59.40% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.60 | - | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $2.00 | +451.10% | 20 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $9.40 | +325.53% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $73.03 | +86.22% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.98 | +506.06% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.79 | +280.32% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $5.36 | +30.60% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $4.12 | +118.45% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $30.79 | +68.89% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $26.07 | +118.64% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.12 | +2,132.14% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.00 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.26 | +360.12% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $34.29 | +22.48% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $26.25 | +14.29% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $9.95 | +0.50% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.67 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $36.90 | +13.82% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.17 | +1,096.58% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.26 | +218.73% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.51 | +3,884.06% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.24 | +167.86% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.41 | +662.46% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.32 | +11,995.03% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.59 | +2,757.38% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.63 | +1,004.29% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.14 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.56 | +2,024.65% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.40 | +685.71% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $19.30 | -63.73% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.66 | +3,676.72% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.77 | +12,819.90% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.57 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.33 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $38.49 | -14.26% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.96 | +1,208.72% | 1 | Mar 24, 2017 |
Q32 Bio
May 5, 2026
Reiterates: Buy
Price Target: $13
Current: $5.19
Upside: +150.48%
Travere Therapeutics
May 5, 2026
Maintains: Buy
Price Target: $47 → $57
Current: $43.82
Upside: +30.08%
Krystal Biotech
May 4, 2026
Reiterates: Buy
Price Target: $310
Current: $286.21
Upside: +8.31%
Clene
May 4, 2026
Reiterates: Buy
Price Target: $31
Current: $7.04
Upside: +340.34%
Esperion Therapeutics
May 1, 2026
Downgrades: Neutral
Price Target: $3.16
Current: $3.13
Upside: +0.96%
XOMA Royalty
Apr 30, 2026
Downgrades: Neutral
Price Target: $39
Current: $41.46
Upside: -5.93%
Ligand Pharmaceuticals
Apr 30, 2026
Maintains: Buy
Price Target: $243 → $289
Current: $231.68
Upside: +24.74%
Compass Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $24
Current: $1.85
Upside: +1,197.30%
Fractyl Health
Apr 24, 2026
Reiterates: Buy
Price Target: $8
Current: $0.70
Upside: +1,039.60%
Shattuck Labs
Apr 20, 2026
Maintains: Buy
Price Target: $6 → $18
Current: $6.64
Upside: +171.08%
Apr 20, 2026
Maintains: Buy
Price Target: $16 → $20
Current: $14.21
Upside: +40.75%
Apr 15, 2026
Reiterates: Buy
Price Target: $15
Current: $1.08
Upside: +1,293.53%
Apr 7, 2026
Maintains: Buy
Price Target: $32 → $13
Current: $6.20
Upside: +109.68%
Mar 31, 2026
Maintains: Buy
Price Target: $4 → $1.2
Current: $0.82
Upside: +45.80%
Mar 24, 2026
Reiterates: Buy
Price Target: $37
Current: $16.55
Upside: +123.56%
Mar 24, 2026
Reiterates: Buy
Price Target: $9
Current: $1.46
Upside: +518.56%
Mar 23, 2026
Reiterates: Buy
Price Target: $6
Current: $1.62
Upside: +271.52%
Mar 23, 2026
Reiterates: Buy
Price Target: $102
Current: $31.95
Upside: +219.25%
Mar 13, 2026
Reiterates: Buy
Price Target: $60
Current: $33.51
Upside: +79.05%
Mar 9, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.66
Upside: -
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $2.50
Upside: +580.00%
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $9.41
Upside: +59.40%
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $2.00
Upside: +451.10%
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $9.40
Upside: +325.53%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $73.03
Upside: +86.22%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $1.98
Upside: +506.06%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.79
Upside: +280.32%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $5.36
Upside: +30.60%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $4.12
Upside: +118.45%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $30.79
Upside: +68.89%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $26.07
Upside: +118.64%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.12
Upside: +2,132.14%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.00
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $3.26
Upside: +360.12%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $34.29
Upside: +22.48%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $26.25
Upside: +14.29%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $9.95
Upside: +0.50%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $36.90
Upside: +13.82%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.17
Upside: +1,096.58%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.26
Upside: +218.73%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.51
Upside: +3,884.06%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.24
Upside: +167.86%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.41
Upside: +662.46%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.32
Upside: +11,995.03%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $0.59
Upside: +2,757.38%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.63
Upside: +1,004.29%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.14
Upside: -
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.56
Upside: +2,024.65%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.40
Upside: +685.71%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $19.30
Upside: -63.73%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.66
Upside: +3,676.72%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.77
Upside: +12,819.90%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.33
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $38.49
Upside: -14.26%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.96
Upside: +1,208.72%